吉林中医药2024,Vol.44Issue(3) :249-252.DOI:10.13463/j.cnki.jlzyy.2024.03.001

吕文良从"肝脾一体"论治非酒精性脂肪性肝病经验

Lv Wenliang's experience in the differentiation and treatment of non-alcoholic fatty liver disease based on the integration of liver and spleen

赵美怡 王少丽 吕文良
吉林中医药2024,Vol.44Issue(3) :249-252.DOI:10.13463/j.cnki.jlzyy.2024.03.001

吕文良从"肝脾一体"论治非酒精性脂肪性肝病经验

Lv Wenliang's experience in the differentiation and treatment of non-alcoholic fatty liver disease based on the integration of liver and spleen

赵美怡 1王少丽 2吕文良2
扫码查看

作者信息

  • 1. 北京中医药大学研究生学院,北京 100020
  • 2. 中国中医科学院广安门医院,北京 100032
  • 折叠

摘要

非酒精性脂肪性肝病随着病情发展可进展为肝硬化、肝癌.吕文良教授基于多年临床经验,认为本病病因与饮食、情志、劳逸相关,基本病机为肝脾不调,气血失和,痰、湿、浊、瘀为本病的主要病理产物.并从"肝脾一体"角度提出三条治则:疏肝理脾,首重益气;祛湿化浊,调气和血;灵活取舍,病证结合.注重个体化综合诊疗,重视患者自身生活方式对本病的影响,治疗效果较好.

Abstract

Non-alcoholic fatty liver disease is a kind of fatty liver disease,which can progress to cirrhosis and liver cancer.Based on many years of clinical experience,Professor Lv Wenliang maintains that the etiology of this disease is related to diet,emotions,and physical exertion,while its basic pathogenesis is the imbalance of liver and spleen,the disharmony between qi and blood,with phlegm,dampness,turbidity and blood stasis as its main pathological products.From the perspective of"liver and spleen integration",he puts forward three treatment principles.The first is to disperse the stagnated liver qi and regulate the spleen,and give a priority to strengthening qi.The second is to remove dampness and resolve turbidity,regulate qi and blood.The third is to choose prescriptions flexibly,and to combine the disease with its syndromes.At the same time,Professor Lv pays attention to delivering an individualized comprehensive diagnosis and treatment,emphasizing the influence of patients'own lifestyle on the disease,which has achieved a significant clinical effect.

关键词

非酒精性脂肪性肝病/肝脾一体/临床经验/吕文良

Key words

non-alcoholic fatty liver disease/integration of liver and spleen/clinical experience/Lv Wenliang

引用本文复制引用

基金项目

国家重点研发计划中医药现代化研究重点专项(2018YFC1705702)

国家自然科学基金面上项目(81774282)

中国中医科学院科技创新工程(CI2021A00801)

中国中医科学院科技创新工程(CI2021A00804)

出版年

2024
吉林中医药
长春中医药大学

吉林中医药

CSTPCD
影响因子:0.843
ISSN:1003-5699
参考文献量20
段落导航相关论文